The Medicinal Chemistry Group has long focused on the design and development of new drugs. We have developed a unique formulation of the active substance, which will be used for nebulization (inhalation) applications against viral diseases. The formulation itself is currently in the preclinical evaluation phase. In the next steps of clinical development, our team cooperates with a wide group of experts, such as prof. MUDr. Martina Vašáková from Thomayer University Hospital.

The report was brought by the website seznamzpravy.cz in the article https://www.seznamzpravy.cz/clanek/babis-cesko-vyrabi-vlastni-lek-na-covid-bude-se-inhalovat-146764 and commented briefly by prof. Jan Konvalinka in Interview ČT24 in time 24:50 https://ct24.ceskatelevize.cz/3282602-interview-ct24-jan-konvalinka-o-koronaviru